10 insiders reported 92 Form 4 transactions for Avalo Therapeutics, Inc. (AVTX) over the past 18 months (most recent 2026-09-18). Recent activity: Sullivan Christopher Ryan (Chief Financial Officer) Sell 12,394 shares, Sullivan Christopher Ryan (Chief Financial Officer) Buy 12,394 shares, Sullivan Christopher Ryan (Chief Financial Officer) Buy 10,185 shares, Sullivan Christopher Ryan (Chief Financial Officer) Sell 10,185 shares, Doyle Mittie (Chief Medical Officer) Buy 679 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 12,394 | $202,437 |
| 2026-09-18 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 12,394 | $122,453 |
| 2026-09-11 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 10,185 | $81,887 |
| 2026-09-11 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 10,185 | $179,457 |
| 2026-09-01 | Doyle Mittie | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-09-01 | Doyle Mittie | Chief Medical Officer | Sell | 679 | $13,580 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 31,031 | $306,586 |
| 2026-08-19 | Doyle Mittie | Chief Medical Officer | Buy | 1,000 | $12,650 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 2,876 | $28,415 |
| 2026-08-19 | Doyle Mittie | Chief Medical Officer | Sell | 1,000 | $20,000 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 37,945 | $753,333 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 3,749 | $74,762 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 37,945 | $374,897 |
| 2026-08-19 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 31,031 | $622,324 |
| 2026-08-12 | Doyle Mittie | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-08-12 | Riley Jennifer | Chief Strategy Officer | Sell | 2,655 | $52,012 |
| 2026-08-12 | Doyle Mittie | Chief Medical Officer | Sell | 679 | $13,580 |
| 2026-07-29 | Doyle Mittie | Chief Medical Officer | Buy | 1,000 | $12,650 |
| 2026-07-29 | Doyle Mittie | Chief Medical Officer | Sell | 1,000 | $20,000 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Buy | 2,875 | $36,369 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Buy | 1,779 | $14,303 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Sell | 4,654 | $93,080 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | Buy | 1,450 | $11,658 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | Sell | 1,450 | $26,100 |
| 2026-06-12 | Riley Jennifer | Chief Strategy Officer | Sell | 588 | $7,703 |
Source: SEC Form 4 filings · as of 2026-09-18